Data Collective Iv Gp, LLC Recursion Pharmaceuticals, Inc. Transaction History
Data Collective Iv Gp, LLC
- $107 Million
- Q3 2024
A detailed history of Data Collective Iv Gp, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Data Collective Iv Gp, LLC holds 5,941,120 shares of RXRX stock, worth $33.9 Million. This represents 36.64% of its overall portfolio holdings.
Number of Shares
5,941,120
Previous 5,941,120
-0.0%
Holding current value
$33.9 Million
Previous $44.6 Million
12.13%
% of portfolio
36.64%
Previous 53.46%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
286Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$187 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$144 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$138 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$98.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$87.7 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.03B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...